SCHEMBL4356632

SCHEMBL4356632

CC(C)(Cc1ccc(Cl)cc1)N(C(=O)c1ccc(-c2cc(F)cc(F)c2)cc1)[C@@H](CCC(=O)O)C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 2/20 0.39
MMP2 P08253 1/20 0.39
MMP8 P22894 1/20 0.39
ADAMTS5 Q9UNA0 1/20 0.39
MME P08473 2/20 0.37
TBXA2R P21731 2/20 0.36
SLC6A9 P48067 1/20 0.34
MAP4K4 O95819 1/20 0.34
MDM2 Q00987 1/20 0.34
RXRA P19793 2/20 0.33
RXRB P28702 2/20 0.33
RXRG P48443 2/20 0.33
ERAP1 Q9NZ08 2/20 0.33
CNR1 P21554 2/20 0.33
CNR2 P34972 1/20 0.33
TSHR P16473 1/20 0.32
GCG P01275 1/20 0.32
TRPM8 Q7Z2W7 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2242485 0.94 MMP2 (0.45) MMP12MMP2MMP8ADAMTS5MME
SCHEMBL2247710 0.92 ADAMTS5 (0.38) MMP12MMP2MMP8ADAMTS5MME
SCHEMBL2249342 0.92 MMP12 (0.43) MMP12MMP2MMP8ADAMTS5RXRA
SCHEMBL2247813 0.89 SLC6A9 (0.34) MMP12MMP2MMP8ADAMTS5MME
SCHEMBL2249890 0.89 MMP12 (0.48) MMP12MMP2MMP8ADAMTS5MME
SCHEMBL2248055 0.88 MMP2 (0.42) MMP12MMP2MMP8ADAMTS5TBXA2R
SCHEMBL2245198 0.87 MMP12 (0.40) MMP12MMP2MMP8ADAMTS5MME
SCHEMBL2247681 0.87 MMP12 (0.45) MMP12MMP2MMP8ADAMTS5MME
SCHEMBL2248769 0.86 MMP12 (0.44) MMP12MMP2MMP8ADAMTS5MME
SCHEMBL2254232 0.85 MMP12 (0.47) MMP12MMP2MMP8ADAMTS5MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553873-B2 Glutamate aggrecanase inhibitors WYETH (US) 2009-06-30 US disclosed
US-20070043066-A1 Glutamate aggrecanase inhibitors WYETH (US) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043066-A1 Glutamate aggrecanase inhibitors ADAMTS5, ADAMTS1, ADAMTS7 MMP12 54/4885MMP2 49/4885MMP8 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.